John K Clarke's Net Worth
$5.08 Million
Who is John K Clarke?
John K Clarke has an estimated net worth of $5.08 Million. This is based on reported shares across multiple companies, which include ALNYLAM PHARMACEUTICALS INC, VISICU INC, Sirtris Pharmaceuticals, Inc., Verastem, Inc., aTYR PHARMA INC, MOMENTA PHARMACEUTICALS INC, CUBIST PHARMACEUTICALS INC, and ATHENAHEALTH INC.
SEC CIK
John K Clarke's CIK is 0001219015
Past Insider Trading and Trends
2005 was John K Clarke's most active year for acquiring shares with 8 total transactions. John K Clarke's most active month to acquire stocks was the month of May. 2014 was John K Clarke's most active year for disposing of shares, totalling 7 transactions. John K Clarke's most active month to dispose stocks was the month of April. 2018 saw John K Clarke paying a total of $409,200.00 for 44,000 shares, this is the most they've acquired in one year. In 2014 John K Clarke cashed out on 70,000 shares for a total of $1,882,978.90, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ALNYLAM PHARMACEUTICALS INC (ALNY) Snapshot price: $246.78
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
$63.80 | -$1,095,477.90 | 8.89K |
Scheduled
|
May 31
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
$33.42 | -$1,426,128.90 |
0
|
Scheduled
|
May 21
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
| +799.73% | 1.86M |
—
|
—
| 2.09M |
Jun 3
| |||
Form 4
|
∞
| 232.5K |
—
|
—
| 232.5K |
May 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
VISICU INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -3.40M |
$12.00 | -$40,775,076.00 |
0
|
Feb 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 4 - Jul 26
| |||
Form 4
| -10.36% | -387.00K |
$10.04 | -$3,884,381.80 | 3.35M |
Nov 30
| |||
Form 4
| -0.31% | -31.50K |
$10.04 | -$316,200.00 | 10.23M |
Nov 16
| |||
Form 4
|
∞
| 3.77M |
—
|
—
| 3.77M |
Apr 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Sirtris Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.07M |
—
|
—
| 2.07M |
May 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Verastem, Inc. (VSTM) Snapshot price: $2.44
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +1.00% | 23.17K |
$9.60 | $222,425.38 | 2.33M |
Jun 12
| |||
Form 4
| +1.10% | 25K |
$9.22 | $230,477.50 | 2.31M |
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
| +1.11% | 25K |
$9.74 | $243,375.00 | 2.28M |
Scheduled
|
May 13
| ||
Form 4
| +0.45% | 10K |
$9.66 | $96,622.00 | 2.26M |
Scheduled
|
May 1
| ||
Form 4
| +0.25% | 5.63K |
$9.50 | $53,488.87 | 2.25M |
Apr 17
| |||
Form 4
| +0.28% | 6.19K |
$7.87 | $48,738.91 | 2.24M |
Scheduled
|
Dec 18
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 6
| |||
Form 4
|
∞
| 2.23M |
$10.00 |
—
| 2.23M |
Feb 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
aTYR PHARMA INC (LIFE) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
| +43.49% | 6K |
—
|
—
| 19.8K |
Apr 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 26
| |||
Form 4
| -2.26% | -2.50K |
$4.34 | -$10,850.00 | 108.08K |
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 28
| |||
Form 4
| -6.24% | -7.36K |
$4.01 | -$29,512.60 | 110.58K |
Aug 28 - Sep 2
| |||
Form 4
| -6.08% | -7.64K |
$4.15 | -$31,700.80 | 117.94K |
Aug 26 - Aug 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 8
| |||
Form 4
| +14,718.93% | 1.85M |
—
|
—
| 1.86M |
May 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |